1-5 of 5
Steve Y Cho
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correlation of Minimal Residual Disease (MRD) at the End of Induction (EOI) and Event Free Survival (EFS) in T-Cell Lymphoblastic Lymphoma (T-LL), a Report from the Children's Oncology Group (COG) Trial AALL1231

Free
Robert J. Hayashi, Michelle L. Hermiston, David T. Teachey, Meenakshi Devidas, Brent L. Wood, Zhiguo Chen, Robert D Annett, Barbara L Asselin, Keith J August, Steve Y Cho, Kimberly P. Dunsmore, Jason L. Freedman, Paul J. Galardy, Paul Harker-Murray, Terzah M. Horton, Alok I Jaju, Allison Lam, Yoav H. Messinger, Rodney R. Miles, Maki Okada, Samir I Patel, Eric S Schafer, Tal Schechter-Finkelstein, Kristin A. Shimano, Neelam Singh, Amii C. Steele, Maria Luisa Sulis, Sarah L Vargas, Stuart S. Winter, Charlotte Wood, Patrick A Zweidler-McKay, Mignon L. Loh, Stephen P. Hunger, Elizabeth A. Raetz, Catherine M Bollard, Carl Allen
Journal: Blood
Blood (2022) 140 (Supplement 1): 6387–6389.
https://doi.org/10.1182/blood-2022-159694
Published: 2022
Journal Articles

Evaluating CHIPS in Pediatric High Risk Hodgkin Lymphoma Treated on AHOD1331

Free
Cindy L Schwartz, Qinglin Pei, Frank G. Keller, Steve Y Cho, David C. Hodgson, Kathleen M McCarten, Yue Wu, Kara M. Kelly, Sharon M. Castellino
Journal: Blood
Blood (2022) 140 (Supplement 1): 6565–6566.
https://doi.org/10.1182/blood-2022-167188
Published: 2022
Journal Articles

Cranial Radiation Can be Eliminated in Most Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Bortezomib Potentially Improves Survival in Children with T-Cell Lymphoblastic Lymphoma (T-LL): Results of Children's Oncology Group (COG) Trial AALL1231

Free
David T. Teachey, MD, Meenakshi Devidas, PhD, Brent L Wood, MD PhD, Zhiguo Chen, MS, Robert James Hayashi, MD, Robert D Annett, PhD, Barbara L Asselin, MD, Keith J August, MDMS, Steve Y Cho, MD, Kimberly P. Dunsmore, MD, Brian T. Fisher, DO, MSCE, Jason L. Freedman, MD, Paul J. Galardy, MD, Paul Harker-Murray, MD PhD, Michelle L. Hermiston, MD PhD, Terzah M Horton, MD PhD, Alok I Jaju, MD, Allison Lam, BCPS, Yoav H. Messinger, MD, Rodney R. Miles, MD PhD, Maki Okada, RN, Samir I Patel, MD, Eric S. Schafer, MD MHS, Tal Schechter-Finkelstein, MD, Kristin A. Shimano, MD, Neelam Singh, PhD, Amii C. Steele, PhD, Maria L. Sulis, MD, Sarah L Vargas, PhD, Stuart S. Winter, MD, Charlotte Wood, CCRP, Patrick Zweider McKay, MDPhD, Catherine M. Bollard, MD MBChB, Mignon L. Loh, MD, Stephen P. Hunger, MD, Elizabeth A. Raetz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-134730
Published: 2020
Journal Articles

Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology Group

Free
Kara M. Kelly, MD, Peter D. Cole, MD, Lu Chen, PhD, Kenneth B Roberts, MD, David C. Hodgson, MD, Kathleen McCarten, MD, Steve Y Cho, MD, Cindy Schwartz, MD
Journal: Blood
Blood (2015) 126 (23): 3927.
https://doi.org/10.1182/blood.V126.23.3927.3927
Published: 2015
Journal Articles

18 f-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL). A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031

Free
Steve Y Cho, MD, Kathleen M McCarten, MD, Lu Chen, PhD, Debra L Friedman, MD, MS, Suzanne L Wolden, MD, Kathryn Karolczuk, Cindy L Schwartz, MD, MPH, Kara M Kelly, MD
Journal: Blood
Blood (2012) 120 (21): 1530.
https://doi.org/10.1182/blood.V120.21.1530.1530
Published: 2012